ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SAG Science Group Plc

410.00
3.00 (0.74%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Science Group Plc LSE:SAG London Ordinary Share GB00B39GTJ17 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.00 0.74% 410.00 400.00 420.00 410.00 407.00 407.00 31,634 10:08:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Consulting Svcs,nec 98.82M 10.56M 0.2322 17.66 186.38M
Science Group Plc is listed in the Business Consulting Svcs sector of the London Stock Exchange with ticker SAG. The last closing price for Science was 407p. Over the last year, Science shares have traded in a share price range of 368.00p to 435.00p.

Science currently has 45,458,972 shares in issue. The market capitalisation of Science is £186.38 million. Science has a price to earnings ratio (PE ratio) of 17.66.

Science Share Discussion Threads

Showing 476 to 500 of 1200 messages
Chat Pages: Latest  24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
13/11/2011
19:09
I have all Of the House Broker notes, so I go with those!
hastings
13/11/2011
19:07
Arbuthnot note on 9th Nov has the following with a Strong Buy and 125p target:

2011: 6.7p
2012: 7.4p
2013: 8.1p


We have valued Sagentia on the basis of a sum-of-the-parts analysis. This is derived either by implying a conservative 9.8x P/E on the 6.7p of diluted EPS we forecast for FY2011 and then adding the 59.2p of NAV , which is essentially the net cash plus the freehold property or alternatively, from a trading point of view, valuing the revenues of the company on an EV/sales multiple of 1.3x, which equates to £30.6m, the net realisable value of the property at £11.4m
(which is probably overly conservative), with last reported net cash of £10.1m. If we divide the total £52.1m by the 41.7m shares in issue, we calculate a value of 125p per share.

doubleorquits
13/11/2011
18:34
I have even different figures to you guys.

According to Company REFS i have Arbuthnots forecast as 7.4p and 8.3 for YE 2011 and 1012 respectively.

That is dated from Sept 27th.

cfro
13/11/2011
18:20
Yes and we are basically at the year end nearly so the 8.6p eps will be the current year eps from Jan 1. If SAG beat the 7.7p eps forecast for this year by anything meaningful then that 8.6p is likely to look very conservative for the year starting Jan 1. I think that would mean a single digit PEfor the new year, £10m net cash at least on a mkt cap of £39m. Tangible assets are likely to rise too with Sphere's float.

They have enough cash to give every shareholder 20p a share or do a share buy back.

Way to cheap imo - but everyone here feels that I'm sure.

CR

cockneyrebel
13/11/2011
17:17
Ditto CR-what is interesting is the subsequent note, which mentioned the recent significant contract underpins the forecasts for 2011-2012 at the very least!
hastings
13/11/2011
16:07
7.7p EPS and 8.6p are the Digital Look EPS numbers for this year and next year. The August note from Arbuthnot.

I don't think there's been any change in that time, I think you might just be looking at one number being an adjusted eps and the other a non-adjusted eps number.

CR

cockneyrebel
13/11/2011
15:35
Hastings, I accessed the forecasts from TDW, I have since looked at other online brokers and financial sites and have found the forecasts to be very variable.

I do find it unlikely that Arbuthnot would raise their target price from 110p to 125p, but at the same time lower their earning forecasts. So I have sent Arbuthnot a message pointing out that many online sites are showing different forecasts.

It looks like a communication error.

Much prefer your forecasts to TDWs.

ic2...

interceptor2
13/11/2011
13:51
Interceptor-there appears to be some discrepancy in the Arbuthnot numbers you have put up. Arbuthnot forecasts from 11th November.

2011, PBT = £3.21m and EPS = 6.7p

2012, PBT = £6.60m and EPS = 7.4p

As you will see below is an extract from the note in August, you will see that the EPS figures are different from above, where did you access those from.






We have been upgrading our PBT forecasts on a regular basis over the last 12-15 months and on the interims increased our 2011 PBT forecast for the third time in recent months to PBT of £3.2m giving EPS of 7.7p on revenues of £23.5m. The revenue growth has been driven by a particularly strong performance from the Medical Sector and an improving performance in the Consumer Sector. As well as stronger revenue growth, profits are also being driven by an improving operating margin. The latter is as a result of the establishment of a high utilisation, tight cost control and lower-risk consultancy operating model. For 2012 we have a PBT forecast of £3.6m on revenues of £25.0m (£24.7m) leading to EPS of 8.6p.

hastings
12/11/2011
16:44
I agree that it's always best to underpromise and over deliver, and it's often the case to see brokers forecast between 10 to 20% below actual results.

Interesting this time last year Arbuthnot were forecasting 60% below the actual results issued in February.

Will be could to have Numis researching SAG.

ic2...

interceptor2
12/11/2011
12:37
Agree CR. It is also worth noting that Arbuthnot state that the recent contract win underpins the recent forecasts, leaving plenty of room for upside. Numis should complete their research very soon,so let's see what they bring to the table. On another matter CCL in Cambridge is doing very well at the moment,not a complete comparison, but as near as you can get,also has an office in Cambridge Mass,like SAG.
hastings
12/11/2011
12:00
A lot of brokers are over cautious at the moment interceptor, due to the market. A lot of co's like to get everything under the belt before giving the nod to brokers too imo.

Undevalued on assets and earnings imo.

CR

cockneyrebel
12/11/2011
11:44
Arbuthnot forecasts from 11th November.

2011, PBT = £3.21m and EPS = 6.7p

2012, PBT = £6.60m and EPS = 7.4p

Am I alone in thinking that Arbuthnot calculations are a complete waste of space, and it's about time SAG had a decent broker following them.

They did the same with IDG last week, which I posted a comment about.

How can they lower their EPS figures after a substantal contract win after their last forecasts, and we know there is no more dilution from now, and SAG still had £27.4m of unused tax credits reported February 2011.

They have a history of being so far behind the curve with SAG before. 21st July 2010 day of Interims Arbuthnot forecast PBT = £1.20m and EPS = 2.8p another 3 upgrades later and they were forecasting EPS = 6.2p on 14 January 2011 which SAG beat in February with 7.0p EPS.

Arbuthnot are best ignored imho.

ic2...

interceptor2
11/11/2011
13:12
Electronica-it appears that Sphere has had little trouble in attracting interest, which is certainly a very good sign.
hastings
11/11/2011
10:12
Noted thanks.
truffle
11/11/2011
09:55
Truffle

Sagentia holds 5.8% of Sphere prior to the placing on Monday. I don't expect SAG to participate in the placing so they will be diluted. We will have to wait until Tuesday to find out how big the dilution is & what the Sphere striking price is.

In the medium term I see SAG selling down the Sphere holding, but I don't expect that they will be disposing of any shares at the placing. It must be difficult enough getting new money raised for Sphere without the extra burden of selling by founding shareholders.

electronica
11/11/2011
09:23
Can someone just clarify when exactly Sphere Medical starts trading, and is it correct to say that Sagentia's stake will be worth 5.8% of the capitalised value of the company?
truffle
10/11/2011
23:39
Yes, nice little write up today (in shares) and with the UK-analyst comments as well SAG are starting to get noticed. Not surprised to see a little pullback after the recent climb and it is near the top of it's (rising) range. There has been a fair bit of selling absorbed of late and like CR says I think some larger orders are being filled as it has held up well. Plenty of news to come here - looks a good one.
greenroom78
10/11/2011
22:46
Cheers truffle and CR. The shares have stood up very well in turbulent times and should continue to do so. Sphere attracted some highly respectable institutions who wouldn't be investing in forlorn hopes right now.Clearly, as others have pointed out, SAG will no doubt look for an early exit given the revised strategy. Numis note should be out very soon now, but I still have an inkling for an acquisition!!
hastings
10/11/2011
18:32
And just seen a really good write-up on Sagentia in this weeks Shares magazine.
It has been rated one of their 5 Top Tips, and a Buy under the 'Brains of Britain five companies with a cutting edge' report, which is their cover story.
The article is worth reading.

truffle
10/11/2011
18:22
Cheers Electronica - a trading update here can't be far off - what target from Arbuthnot when the co comes out ahead of forecasts - as I suspect they will be?

Will be intteresting to see what SAG's stake in Sphere is worth next week.

CR

cockneyrebel
10/11/2011
18:12
This from UK Analyst's Newsletter today ...........

"Sagentia (SAG) kept its "strong buy" rating from Arbuthnot Securities, with an increased target price of 125p from 110p. The broker is impressed with technology consultant's ability to improve its margins, growing from a 0.3 million pounds pre-tax loss in 2009 to an expected 3.2 million pound pre-tax profit in 2011, on fairly constant revenues of 23.4 million pounds and 23.5 million pounds respectively. Arbuthnot adds that the recent 10 million dollar (6.3 million pound) contract win, which will last three years, improves revenue visibility. Shares in Sagentia slipped 0.5p to 92.p."

electronica
10/11/2011
17:49
Sphere Medical entera AIM on Tuesday - seems SAG have 5.8% after the increase in shares in the float.

Will be interesting next week.

CR

cockneyrebel
09/11/2011
07:00
The encouraging thing about last Fridays break up over 88p, is that sellers emerged on Friday, 7 transactions of 100k shares. But the share price increased slightly during the selling.

So investors that brought at July's high of 88p, and were waiting for an opportunity to break even after the share price went to 74p a few weeks afterwards could very likely be out now.

Very positive imo.

ic2...

interceptor2
07/11/2011
22:06
Well you can't ask for better than that.
hastings
07/11/2011
22:01
It has rated 9 on the piotroski screen.
russman
Chat Pages: Latest  24  23  22  21  20  19  18  17  16  15  14  13  Older

Your Recent History

Delayed Upgrade Clock